Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 3/2010

01.03.2010 | 2009 SSAT Plenary Presentation

Colonic Gene Expression in Conventional and Germ-Free Mice with a Focus on the Butyrate Receptor GPR109A and the Butyrate Transporter SLC5A8

verfasst von: Gail A. Cresci, Muthusamy Thangaraju, John D. Mellinger, Kebin Liu, Vadivel Ganapathy

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Butyrate is a bacterial fermentation product that produces its beneficial effects on colon through GPR109A, a butyrate receptor, and SLC5A8, a butyrate transporter. In this study, we compared the expression of GPR109A and SLC5A8 between conventional mice and germ-free mice to test the hypothesis that the expression of these two proteins will be decreased in germ-free mice compared to conventional mice because of the absence of bacterial fermentation products and that colonization of germ-free mouse colon with conventional bacteria will reverse these changes.

Methods

RNA was prepared from the ileum and colon of conventional mice and germ-free mice and used for RT-PCR to determine mRNA levels. Tissue sections were used for immunohistochemical analysis to monitor the expression of GPR109A and SLC5A8 at the protein level. cDNA microarray was used to determine the differential expression of the genes in the colon between conventional mice and germ-free mice.

Results

In conventional mice with normal bacterial colonization of the intestinal tract, GPR109A and SLC5A8 are expressed on the apical membrane of epithelial cells lining the ileum and colon. In germ-free mice, the expression of GPR109A and SLC5A8 is reduced markedly in the ileum and colon. The expression returns to normal levels when the intestinal tract of germ-free mice is colonized with bacteria. The expression of the Na+-coupled glucose transporter, SGLT1, follows a similar pattern. Microarray analysis identifies ∼700 genes whose expression is altered more than twofold in germ-free mice compared to conventional mice. Among these genes are the chloride/bicarbonate exchanger SLC26A3 and the water channel aquaporin 4. The expression of SLC26A3 and AQP4 in ileum and colon is reduced in germ-free mice, but the levels return to normal upon bacterial colonization.

Conclusion

Gut bacteria play an active role in the control of gene expression in the host intestinal tract, promoting the expression of the genes that are obligatory for the biological actions of the bacterial fermentation product butyrate and also the genes that are related to electrolyte and water absorption.
Literatur
1.
Zurück zum Zitat Hooper LVE, Midtvedt T, Gordon JI. How host–microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 2002;22:283–307.CrossRefPubMed Hooper LVE, Midtvedt T, Gordon JI. How host–microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 2002;22:283–307.CrossRefPubMed
2.
Zurück zum Zitat Backhed F, Ley R, Sonnenburg JL, Peterson DA, Gordon JI. Host–bacterial mutualism in the human intestine. Science 2005;307:1915–1920.CrossRefPubMed Backhed F, Ley R, Sonnenburg JL, Peterson DA, Gordon JI. Host–bacterial mutualism in the human intestine. Science 2005;307:1915–1920.CrossRefPubMed
3.
Zurück zum Zitat Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977;31:107–133.CrossRefPubMed Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977;31:107–133.CrossRefPubMed
4.
Zurück zum Zitat Peterson DA, Frank DN, Pace NR, Gordon JI. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 2008;3:417–427.CrossRefPubMed Peterson DA, Frank DN, Pace NR, Gordon JI. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 2008;3:417–427.CrossRefPubMed
5.
Zurück zum Zitat Mitsuyama K, Sata M. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease. Expert Opin Ther Targets 2008;12:301–312.CrossRefPubMed Mitsuyama K, Sata M. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease. Expert Opin Ther Targets 2008;12:301–312.CrossRefPubMed
6.
Zurück zum Zitat Knight P, Campbell BJ, Rhodes JM. Host–bacteria interaction in inflammatory bowel disease. Br Med Bul 2008;88:95–113.CrossRefPubMed Knight P, Campbell BJ, Rhodes JM. Host–bacteria interaction in inflammatory bowel disease. Br Med Bul 2008;88:95–113.CrossRefPubMed
7.
Zurück zum Zitat Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001;81:1031–1064.PubMed Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001;81:1031–1064.PubMed
8.
Zurück zum Zitat Mortensen PB, Clausen MR. Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol 1996;216:132–148.CrossRef Mortensen PB, Clausen MR. Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol 1996;216:132–148.CrossRef
9.
Zurück zum Zitat Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 2006;40:235–243.CrossRefPubMed Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 2006;40:235–243.CrossRefPubMed
10.
Zurück zum Zitat Sellin JH. SCFAs: the enigma of weak electrolyte transport in the colon. News Physiol Sci 1999;14:58–64.PubMed Sellin JH. SCFAs: the enigma of weak electrolyte transport in the colon. News Physiol Sci 1999;14:58–64.PubMed
11.
Zurück zum Zitat Roy CC, Kien CL, Bouthillier L, Levy E. Short-chain fatty acids: ready for prime time? Nutr Clin Pract 2006;21:351–366.CrossRef Roy CC, Kien CL, Bouthillier L, Levy E. Short-chain fatty acids: ready for prime time? Nutr Clin Pract 2006;21:351–366.CrossRef
12.
Zurück zum Zitat Bordonaro M, Lazarova DL, Sartorelli AC. Butyrate and Wnt signaling. Cell Cycle 2008;7:1178–1183.PubMed Bordonaro M, Lazarova DL, Sartorelli AC. Butyrate and Wnt signaling. Cell Cycle 2008;7:1178–1183.PubMed
13.
Zurück zum Zitat Miyauchi S, Gopal E, Fei YJ , Ganapathy, V. Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na+-coupled transporter for short-chain fatty acids. J Biol Chem 2004;279:13293–13296.CrossRefPubMed Miyauchi S, Gopal E, Fei YJ , Ganapathy, V. Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na+-coupled transporter for short-chain fatty acids. J Biol Chem 2004;279:13293–13296.CrossRefPubMed
14.
Zurück zum Zitat Coady MJ, Chang MH, Charron FM, Plata C, Wallendorff B, Sah J et al. The human tumour suppressor gene SLC5A8 expresses a Na+-monocarboxylate cotransporter. J Physiol 2004;557:719–731.CrossRefPubMed Coady MJ, Chang MH, Charron FM, Plata C, Wallendorff B, Sah J et al. The human tumour suppressor gene SLC5A8 expresses a Na+-monocarboxylate cotransporter. J Physiol 2004;557:719–731.CrossRefPubMed
15.
Zurück zum Zitat Gopal E, Miyauchi S, Martin PM, Ananth S, Roon P, Smith SB, Ganapathy V. Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract. Pharm Res 2007;24:575–584.CrossRefPubMed Gopal E, Miyauchi S, Martin PM, Ananth S, Roon P, Smith SB, Ganapathy V. Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract. Pharm Res 2007;24:575–584.CrossRefPubMed
16.
Zurück zum Zitat Takebe K, Nio J, Morimatsu M, Karaki S, Kuwahara A, Kato I et al. Histochemical demonstration of a Na+-coupled transporter for short-chain fatty acids (slc5a8) in the intestine and kidney of the mouse. Biomed Res 2005;26:213–221.CrossRefPubMed Takebe K, Nio J, Morimatsu M, Karaki S, Kuwahara A, Kato I et al. Histochemical demonstration of a Na+-coupled transporter for short-chain fatty acids (slc5a8) in the intestine and kidney of the mouse. Biomed Res 2005;26:213–221.CrossRefPubMed
17.
Zurück zum Zitat Thangaraju M, Cresci GA, Itagaki S, Mellinger JD, Browning DD, Berger FG, Prasad PD, Ganapathy V. Sodium-coupled transport of the short chain fatty acid butyrate by SLC5A8 and its relevance to colon cancer. J Gastrointest Surg 2008;12:1773–1781.CrossRefPubMed Thangaraju M, Cresci GA, Itagaki S, Mellinger JD, Browning DD, Berger FG, Prasad PD, Ganapathy V. Sodium-coupled transport of the short chain fatty acid butyrate by SLC5A8 and its relevance to colon cancer. J Gastrointest Surg 2008;12:1773–1781.CrossRefPubMed
18.
Zurück zum Zitat Ganapathy V, Gopal E, Miyauchi S, Prasad PD. Biological functions of SLC5A8, a candidate tumour suppressor. Biochem Soc Trans 2005;33:237–240.CrossRefPubMed Ganapathy V, Gopal E, Miyauchi S, Prasad PD. Biological functions of SLC5A8, a candidate tumour suppressor. Biochem Soc Trans 2005;33:237–240.CrossRefPubMed
19.
Zurück zum Zitat Gupta N, Martin PM, Prasad PD, Ganapathy V. SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter. Life Sci 2006;78:2419–2425.CrossRefPubMed Gupta N, Martin PM, Prasad PD, Ganapathy V. SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter. Life Sci 2006;78:2419–2425.CrossRefPubMed
20.
Zurück zum Zitat Ganapathy V, Thangaraju M, Gopal E, Itagaki S, Miyauchi S, Prasad, PD. Sodium-coupled monocarboxylate transporters in normal tissues and in cancer. AAPS J 2008;10:193–199.CrossRefPubMed Ganapathy V, Thangaraju M, Gopal E, Itagaki S, Miyauchi S, Prasad, PD. Sodium-coupled monocarboxylate transporters in normal tissues and in cancer. AAPS J 2008;10:193–199.CrossRefPubMed
21.
Zurück zum Zitat Ganapathy V, Thangaraju M, Prasad PD. Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond. Pharmacol Ther 2009;121:29–40.CrossRefPubMed Ganapathy V, Thangaraju M, Prasad PD. Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond. Pharmacol Ther 2009;121:29–40.CrossRefPubMed
22.
Zurück zum Zitat Thangaraju M, Cresci GA, Liu K, Ananth S, Gnanaprakasam JP, Browning DD et al. GPR109A is a G-protein coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res 2009;69:2826–2832.CrossRefPubMed Thangaraju M, Cresci GA, Liu K, Ananth S, Gnanaprakasam JP, Browning DD et al. GPR109A is a G-protein coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res 2009;69:2826–2832.CrossRefPubMed
23.
Zurück zum Zitat Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host–microbial relationships in the intestine. Science 2001;291:881–884.CrossRefPubMed Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host–microbial relationships in the intestine. Science 2001;291:881–884.CrossRefPubMed
24.
Zurück zum Zitat Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 2003;4:269–273.CrossRefPubMed Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 2003;4:269–273.CrossRefPubMed
25.
Zurück zum Zitat Gopal E, Umapathy NS, Martin PM, Gnana-Prakasam JP, Becker H, Wagner CA et al. Cloning and functional characterization of human SMCT2 (SLC5A12) and expression pattern of the transporter in kidney. Biochim Biophys Acta 2007;1768:2690–2697.CrossRefPubMed Gopal E, Umapathy NS, Martin PM, Gnana-Prakasam JP, Becker H, Wagner CA et al. Cloning and functional characterization of human SMCT2 (SLC5A12) and expression pattern of the transporter in kidney. Biochim Biophys Acta 2007;1768:2690–2697.CrossRefPubMed
26.
Zurück zum Zitat Martin PM, Ananth S, Cresci GA, Roon P, Smith SB, Ganapathy V. Expression and localization of GPR109A (PUMA-G/HM74A) mRNA and protein in mammalian retinal pigment epithelium. Mol Vis 2009;15:362–372.PubMed Martin PM, Ananth S, Cresci GA, Roon P, Smith SB, Ganapathy V. Expression and localization of GPR109A (PUMA-G/HM74A) mRNA and protein in mammalian retinal pigment epithelium. Mol Vis 2009;15:362–372.PubMed
27.
Zurück zum Zitat Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863–14868.CrossRefPubMed Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863–14868.CrossRefPubMed
28.
Zurück zum Zitat Liu K, Caldwell SA, Abrams SI. Immune selection and emergence of aggressive tumor variants as negative consequences of Fas-mediated cytotoxicity and altered IFN-gamma-regulated gene expression. Cancer Res 2005;65:4376–4388.CrossRefPubMed Liu K, Caldwell SA, Abrams SI. Immune selection and emergence of aggressive tumor variants as negative consequences of Fas-mediated cytotoxicity and altered IFN-gamma-regulated gene expression. Cancer Res 2005;65:4376–4388.CrossRefPubMed
29.
Zurück zum Zitat Wise A, Foord SM, Fraser JN, Barnes AA, Elshourbagy N, Eilert M et al. Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem 2003;278:9869–9874.CrossRefPubMed Wise A, Foord SM, Fraser JN, Barnes AA, Elshourbagy N, Eilert M et al. Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem 2003;278:9869–9874.CrossRefPubMed
30.
Zurück zum Zitat Tunaru S, Kero J, Schaub A, Wufka C, Blaukat A, Pfeffer K et al. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med 2003;9:352–355.CrossRefPubMed Tunaru S, Kero J, Schaub A, Wufka C, Blaukat A, Pfeffer K et al. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med 2003;9:352–355.CrossRefPubMed
31.
Zurück zum Zitat Taggart AKP, Kero J, Gan X, Cai TQ, Cheng K et al. (D)-β-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem 2005;280:26649–26652.CrossRefPubMed Taggart AKP, Kero J, Gan X, Cai TQ, Cheng K et al. (D)-β-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem 2005;280:26649–26652.CrossRefPubMed
32.
Zurück zum Zitat Ganguly NK, Kaur T. Mechanism of action of cholera toxin & other toxins. Ind J Med Res 1996;104:28–37. Ganguly NK, Kaur T. Mechanism of action of cholera toxin & other toxins. Ind J Med Res 1996;104:28–37.
33.
Zurück zum Zitat Field M, Semrad CE. Toxigenic diarrheas, congenital diarrheas, and cystic fibrosis: Disorders of intestinal ion transport. Annu Rev Physiol 1993;55:631–655.CrossRefPubMed Field M, Semrad CE. Toxigenic diarrheas, congenital diarrheas, and cystic fibrosis: Disorders of intestinal ion transport. Annu Rev Physiol 1993;55:631–655.CrossRefPubMed
34.
Zurück zum Zitat Field M. Intestinal ion transport and the pathophysiology of diarrhea. J Clin Invest 2003;111:931–943.PubMed Field M. Intestinal ion transport and the pathophysiology of diarrhea. J Clin Invest 2003;111:931–943.PubMed
Metadaten
Titel
Colonic Gene Expression in Conventional and Germ-Free Mice with a Focus on the Butyrate Receptor GPR109A and the Butyrate Transporter SLC5A8
verfasst von
Gail A. Cresci
Muthusamy Thangaraju
John D. Mellinger
Kebin Liu
Vadivel Ganapathy
Publikationsdatum
01.03.2010
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 3/2010
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-009-1045-x

Weitere Artikel der Ausgabe 3/2010

Journal of Gastrointestinal Surgery 3/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.